New Product Development
The global oligonucleotide API market is poised for significant growth, with demand projected to rise at a robust compound annual growth rate (CAGR) of 5.6% from 2024 to 2034. The market, valued at USD 2.81 billion in 2024, is anticipated to reach USD 4.84 billion by the end of 2034, driven by the growing need …
Continue reading “Oligonucleotide API Industry to Reach USD 4.84 Billion by 2034 at 5.60% CAGR”
The Oligonucleotide API Market is on track for a promising future, fueled by the increasing demand for innovative drug therapies. According to a recent market analysis, the market is currently valued at US$2.81 billion in 2024. This positive trend is expected to continue, with a projected Compound Annual Growth Rate (CAGR) of 5.60% over the …
The Global Oligonucleotide API Market is poised for substantial growth between 2022 and 2030, with a robust CAGR of 10.2%, primarily driven by the increasing demand for innovative drug classes. Consequently, it is projected that by the close of 2030, the global market for oligonucleotide Active Pharmaceutical Ingredients (APIs) will have surged from a valuation of US$ …
The Global Oligonucleotide (API) Industry is on the verge of a remarkable transformation, with a forecasted Compound Annual Growth Rate (CAGR) of 10.2% between 2022 and 2030. This substantial growth is fueled by the surging demand for innovative drug classes, making it one of the most promising sectors in the pharmaceutical industry. According to a …
